US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anchiano Therapeutics Ltd.

4.71

0.0000

Volume:- -

Turnover:- -

Market Cap:546.05K

PE:-0.19

High:4.71

Open:4.71

Low:4.71

Close:4.71

52wk High:168.80

52wk Low:4.71

Shares:115.94K

Float Shares:48.28K

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-25.0336

EPS(LYR):-25.0336

ROE:-125.60%

ROA:-52.84%

PB:0.15

PE(LYR):-0.19

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Anchiano Therapeutics Ltd.

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.anchiano.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Anchiano Therapeutics Ltd., a preclinical biotechnology company, discovers, develops, and commercializes small molecule anti-cancer therapies. It primarily develops Pan-RAS Program that identifies novel indene-based small molecules that exhibit potent and selective inhibition of activated RAS signaling regardless of isoform or mutation; and PDE10/Ã-catenin program, which identifies small molecules that selectively and potently inhibit PDE10 and suppress Wnt/APC/Ã-catenin signaling in preclinical models. Anchiano Therapeutics Ltd. has collaboration and license agreement with ADT Pharmaceuticals, LLC to research and develop programs related to the pan-RAS and PDE10/Ã-catenin programs. The company was formerly known as BioCancell Ltd. and changed its name Anchiano Therapeutics Ltd. in July 2018. Anchiano Therapeutics Ltd. was founded in 2004 and is headquartered in Cambridge, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ANCN/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANCN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANCN\",,,,,undefined,":{"symbol":"ANCN","market":"US","secType":"STK","nameCN":"Anchiano Therapeutics Ltd.","latestPrice":4.71,"timestamp":1615924800000,"preClose":4.71,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":48282,"shares":115935,"eps":-25.033552,"marketStatus":"Pre-Mkt","change":0,"latestTime":"05-19 07:44:53 EDT","open":4.71,"high":4.71,"low":4.71,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-25.033552,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779197400000},"marketStatusCode":1,"symbolChange":{"newSymbol":"CMMB","executeDate":"2021-03-17"},"adr":0,"adrRate":5,"listingDate":1549947600000,"exchange":"NASDAQ","adjPreClose":4.71,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANCN\",,,,,undefined,":{"symbol":"ANCN","floatShares":48282,"roa":"-52.84%","roe":"-125.60%","lyrEps":-25.033552,"shares":115935,"dividePrice":0,"high":4.71,"amplitude":0,"preClose":4.71,"low":4.71,"week52Low":4.71,"pbRate":"0.15","week52High":168.8,"institutionHeld":0,"latestPrice":4.71,"eps":-25.033552,"divideRate":0,"volume":0,"delay":0,"ttmEps":-25.033552,"open":4.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANCN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-03-17","symbol":"ANCN","defaultRemindTime":1615987800000,"type":"split","dateTimestamp":1615953600000,"forFactor":16,"toFactor":1,"ratio":16},{"market":"US","date":"2021-03-17","symbol":"ANCN","oldSymbol":"ANCN","defaultRemindTime":1615987800000,"newSymbol":"CMMB","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1615953600000},{"market":"US","date":"2021-03-09","symbol":"ANCN","fiscalQuarterEnding":"2020/12","expectedEps":-0.5,"name":null,"time":"","type":"earning","dateTimestamp":1615266000000,"reportTimeType":"","actualEps":-0.25},{"date":"2020-11-20","symbol":"ANCN","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":"2020/09","expectedEps":-0.45,"defaultRemindTime":1605862800000,"name":null,"time":"","dateTimestamp":1605848400000,"actualEps":-0.35},{"market":"US","date":"2020-08-14","symbol":"ANCN","fiscalQuarterEnding":"2020/06","expectedEps":-0.55,"name":null,"time":"","type":"earning","dateTimestamp":1597377600000,"reportTimeType":"","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANCN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANCN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANCN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANCN","date":"2021-03-12","current":-0.188147,"percent":0.217476,"low":-7.363218,"twenty":-2.897664,"median":-0.852033,"eighty":-0.401216,"high":-0.164132,"avg":-1.611669,"sd":1.670567,"marketCap":32499030},"quantilePoints":[],"updateTime":1779188211276},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.anchiano.com","stockEarnings":[{"period":"1week","weight":-0.9375},{"period":"1month","weight":-0.9375},{"period":"3month","weight":-0.9375},{"period":"6month","weight":-0.9375},{"period":"1year","weight":-0.9375},{"period":"ytd","weight":-0.9375}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Anchiano Therapeutics Ltd., a preclinical biotechnology company, discovers, develops, and commercializes small molecule anti-cancer therapies. It primarily develops Pan-RAS Program that identifies novel indene-based small molecules that exhibit potent and selective inhibition of activated RAS signaling regardless of isoform or mutation; and PDE10/Ã-catenin program, which identifies small molecules that selectively and potently inhibit PDE10 and suppress Wnt/APC/Ã-catenin signaling in preclinical models. Anchiano Therapeutics Ltd. has collaboration and license agreement with ADT Pharmaceuticals, LLC to research and develop programs related to the pan-RAS and PDE10/Ã-catenin programs. The company was formerly known as BioCancell Ltd. and changed its name Anchiano Therapeutics Ltd. in July 2018. Anchiano Therapeutics Ltd. was founded in 2004 and is headquartered in Cambridge, Massachusetts.","exchange":"NASDAQ","name":"Anchiano Therapeutics Ltd.","nameEN":"Anchiano Therapeutics Ltd.","securityTypeName":"DR","adrRate":"1:5"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ANCN\",market:\"US\",,,undefined,":null}}